Mwg Management Ltd. has filed its 13F form on August 13, 2024 for Q2 2024 where it was disclosed a total value porftolio of $91.6 Million distributed in 3 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Beam Therapeutics Inc. with a value of $53.1M, Lyell Immunopharma, Inc. with a value of $29.2M, and Prime Medicine, Inc. with a value of $9.21M.

Examining the 13F form we can see an decrease of $43.5M in the current position value, from $135M to 91.6M.

Mwg Management Ltd. is based out at Washington, DC

Below you can find more details about Mwg Management Ltd. portfolio as well as his latest detailed transactions.

Portfolio value $91.6 Million
Healthcare: $82.3 Million

Stock Holdings Table Market Cap. of $50 Millions to $300 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 3
  • Current Value $91.6 Million
  • Prior Value $135 Million
  • Filing
  • Period Q2 2024
  • Filing Date August 13, 2024
  • Form Type 13F-HR
  • Activity in Q2 2024
  • New Purchases 0 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 1 stocks
Track This Portfolio

Track Mwg Management Ltd. Portfolio

Follow Mwg Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mwg Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mwg Management Ltd. with notifications on news.